Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
Canopy Growth (TSX: WEED, NASDAQ: CGC), a leading cannabis company, will announce its fourth quarter and fiscal year 2024 financial results on May 30, 2024, before market open. The results cover the period ending March 31, 2024. Following the release, CEO David Klein and CFO Judy Hong will host an audio webcast at 10 AM ET.
The webcast can be accessed live and will be available for replay until August 28, 2024. Canopy Growth offers a wide range of premium and mainstream cannabis products and has a significant presence in the U.S. THC market through partnerships with brands like Wana, Jetty Extracts, and Acreage Holdings.
Canopy Growth is also committed to social equity, responsible use, and community reinvestment, aiming to improve lives through cannabis products and education.
Canopy Growth announced that Canopy USA, has exercised options to acquire Wana, a leading cannabis edibles brand, and Jetty, a California-based producer of high-quality cannabis extracts. These acquisitions are expected to drive revenue growth, realize cost synergies, and establish a brand-focused powerhouse in the U.S. cannabis market. Canopy USA will own 100% of Wana and approximately 75% of Jetty upon closing, subject to regulatory approvals.
Canopy Growth announced a financing agreement with an institutional investor to receive approximately US$50 million in gross proceeds and exchange C$27.5 million of existing debt for a new senior unsecured convertible debenture. The company intends to use the proceeds for working capital and general corporate purposes. The offering is expected to close in May 2024, subject to customary conditions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.